LI vs ZYME · P/E 24, rev $16.06B vs rev $76.3M
Li Auto Inc (LI) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Li Auto Inc (LI) is a auto manufacturers company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported LI revenue for 2025-12-31 was $16.06B. Net income was $162.9M. Revenue was down 18.8% from 2024-12-31 to 2025-12-31. LI currently screens at market cap $26.62B and trailing P/E 24.2.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
LI currently screens at market cap $26.62B and trailing P/E 24.2. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the LI and ZYME stock pages for the full models.
Not investment advice.